Corporate GovernanceApr 27, 2026, 06:08 AM
SYRA Amends 10-K to Add Part III Info; New CEO Comp
AI Summary
Syra Health Corp. filed an Amendment No. 1 to its Annual Report on Form 10-K for fiscal year 2025 to include previously omitted information regarding directors, executive compensation, security ownership, related party transactions, and principal accountant fees. The amendment details the appointment of Gregory R. Alexander as CEO, the termination of former CEO Deepika Vuppalanchi, and the passing of former President Sandeep Allam. It also outlines compensation for executives and directors, and discloses related party transactions.
Key Highlights
- Gregory R. Alexander appointed CEO effective January 5, 2026, with $251,000 annual base salary.
- CEO Alexander granted 110,537 restricted stock units and 257,920 stock options.
- Former CEO Deepika Vuppalanchi's employment terminated for cause on June 13, 2025.
- Priya Prasad's 2025 total compensation was $272,964, including interim CEO allowance.
- Non-employee directors receive $20,000 annual cash compensation, plus committee fees.
- Related party office lease expenses were $111,990 in 2025.
- Related party IT services expenses were $340,757 in 2025.
- M&K audit fees were $75,000 and audit-related fees $17,000 in 2024.